|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 296.05 USD | -0.55% |
|
+1.41% | -25.38% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 441.31 | +48.24% | 26 | ||||||
| 1,215.79 | +6.21% | 29 | ||||||
| 252.87 | +6.7% | 23 | ||||||
| 253.55 | +12.48% | 29 | ||||||
| 360.76 | +13.16% | 17 | ||||||
| 220.95 | +21.08% | 21 | ||||||
| 155.2 | +4.5% | 21 | ||||||
| 352.5 | +2.3% | 30 | ||||||
| 311.78 | +15.69% | 23 | ||||||
| 157.83 | +25.76% | 29 | ||||||
| 29.19 | +13.57% | 27 | ||||||
| 63.08 | +11.69% | 25 | ||||||
| 548.69 | +23.09% | 29 | ||||||
| 97.1 | +26.03% | 23 | ||||||
| 20.61 | +8.27% | 19 | ||||||
| 9,973.33 | +35.21% | 15 | ||||||
| 6,136.87 | +23.35% | 15 | ||||||
| 81.26 | +75.21% | 16 | ||||||
| 49.47 | +39.4% | 19 | ||||||
| 4.175 | +24.43% | 17 | ||||||
| Average | 1,036.32 | +21.82% | 23 | ||||||
| Weighted average by Cap. | 708.28 | +12.93% | 25 |
- Stock Market
- Stocks
- ALNY Stock
- Sector Alnylam Pharmaceuticals, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
